Hepatitis c treatment

Xem 1-20 trên 71 kết quả Hepatitis c treatment
  • Hepatitis C treatment management is an ever-changing field. The publishers and authors of “The Flying Publisher Guide to Hepatitis C treatment “ have made every effort to provide information that is accurate and complete as of the date of publication. However, in view of the rapid changes occurring in Hepatitis C management, as well as the possibility of human error, this site may contain technical inaccuracies, typographical or other errors. It is the responsibility of the physician who relies on experience and...

    pdf0p possibletb 28-11-2012 34 0   Download

  • Since the discovery of hepatitis C virus (HCV) in 1989, there has been an explosion of research and information on the virus. This is evidenced by the more than 20 000 papers onHCV(as of December, 2000), as well as the numerous reviews in journals and edited books. The purpose of this book is to present an overview of the diVerent disciplines that have contributed to an understanding of the virus, its diseases, current and proposed treatments, and much more.

    pdf272p gian_anh 18-10-2012 46 5   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Hepatitis C Treatment: current and future perspectives

    pdf6p dauphong2 23-12-2011 23 2   Download

  • Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: Reliability and predictive validity of a hepatitisrelated symptom inventory in HIV-infected individuals referred for Hepatitis C treatment...

    pdf9p toshiba23 18-11-2011 52 1   Download

  • Chronic hepatitis C virus (HCV) infection is a main health problem in Egypt causing high rates of mortalities. Egypt has the highest HCV prevalence in the world, with specific HCV subtypes epidemic and circulating extensively in the country. Different antiviral therapy protocols have been implemented for treating Egyptian HCV patients. Due to the limited data about HCV in Egypt, this study aimed to genotype HCV strains circulating in the Nile Delta Damietta governorate and to investigate the variation in the nonstructural 5B (NS5B) region targeted by the newly approved antiviral drugs.

    pdf9p trinhthamhodang1 14-11-2019 5 0   Download

  • Hepatitis-C (HCV) infection can induce kidney injury, mostly due to formation of immunecomplexes and cryoglobulins, and possibly to a direct cytopathic effect. It may cause acute kidney injury (AKI) as a part of systemic vasculitis, and augments the risk of AKI due to other etiologies. It is responsible for mesangiocapillary or membranous glomerulonephritis, and accelerates the progression of chronic kidney disease due to other causes. HCV infection increases cardiovascular and liver-related mortality in patients on regular dialysis.

    pdf18p kequaidan1 16-11-2019 22 0   Download

  • Chronic hepatitis C virus (HCV) infection is a systemic disease that leads to increased risks of cirrhosis and its complications, as well as extrahepatic disturbances, including immune-related disorders and metabolic alterations such as insulin resistance and steatosis. Recent accumulating evidence suggests that HCV infection can increase cardiovascular risk, and that viral eradication can improve cardiovascular outcomes in the clinical setting. These data are strengthened by evidence identifying potential mechanisms (in)directly linking HCV infection to vascular damage.

    pdf8p kequaidan1 16-11-2019 7 0   Download

  • An association between hepatitis C virus infection and neuropsychiatric symptoms has been proposed for some years. A variety of studies have been undertaken to assess the nature and severity of these symptoms, which range from fatigue and depression to defects in attention and verbal reasoning. There is evidence of mild neurocognitive impairment in some patients with HCV infection, which is not fully attributable to liver dysfunction or psychosocial factors.

    pdf10p kequaidan1 16-11-2019 15 0   Download

  • Egypt has the highest prevalence of hepatitis C virus (HCV) worldwide. Currently, combined pegylated interferon and ribavirin therapy are the standard treatment. The biological activity of interferon (IFN) is mediated by the induction of intracellular antiviral proteins, such as 20 –50 oligoadenylate synthetase, and dsRNA-activated protein kinase. IFN-inducible doublestranded RNA-activated protein kinase (PKR) is thought to play a key antiviral role against HCV. Some studies observed that PKR expression was higher in sustained viral responders compared with the non-responders.

    pdf7p kethamoi1 17-11-2019 8 0   Download

  • To determine whether the soluble programmed cell death ligand 1 (sPD-L1) levels in patients with chronic hepatitis C (CHC) are associated with the clinical features of the disease and the efficacy of treatment, including interferon (IFN)-α.

    pdf9p vilusaka2711 19-11-2019 6 0   Download

  • The epidemiology of viral hepatitis and syphilis in antenatal patient is of paramount importance for health planner and program managers. This study was conducted to assess to know the seroprevalnce of Hepatitis B Hepatitis C and syphilis in antenatal patient and to re-evaluate the need for routine antenatal care screening. All samples were tested to detect HbsAg by enzyme linked immunosorbent assay (ELISA), anti HCV antibody by ELISA and antibodies to Treponema palladium by qualitative Rapid Plasma Regain (RPR). Total 1000 samples were tested.

    pdf6p caygaocaolon3 27-02-2020 18 0   Download

  • This study is a cross-sectional study aimed to assess the rate of occurrence of secondary occult hepatitis C virus (HCV) infection in patients treated with the combination of sofosbuvir and daclatasvir. This study included 40 patients whose serum turned negative for HCV ribonucleic acid (HCV RNA) via real time polymerase chain reaction (RT-PCR) after 3 months of the treatment. Blood samples on EDTA were collected from the patients to detect HCV RNA in peripheral blood mononuclear cells (PBMCs).

    pdf9p trinhthamhodang4 22-03-2020 5 0   Download

  • Thalassemia is an autosomal recessive disease causing haemolytic anaemia. The ideal treatment of these patients involves regular, 2-4 weekly blood transfusions. The major complications by this treatment are the transmission of transfusion acquired infections such as Hepatitis B virus infection, Hepatitis C virus infection, Human immunodeficiency virus infection, Syphilis, Malaria and transfusion acquired iron overload.

    pdf5p kequaidan4 05-05-2020 1 0   Download

  • Hepatitis C treatment is currently facing many challenges, such as high costs of medicines, side effects in patients, and low success rates with Hepatitis C Virus genotype 1b (HCV-1b). In order to identify what characteristics of HCV-1b cause drug resistance, many sequence analysis methods are conducted, and bio-markers helping to predict failure rates are also proposed. However, the results may be imprecise when these methods work with a dataset having a small number of labeled sequences and short length sequences.

    pdf11p caygaocaolon6 22-07-2020 5 0   Download

  • Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment...

    pdf7p thulanh9 07-10-2011 33 1   Download

  • B-cell NHL is strongly associated with HCV that was proved in the last 2 decades. The most common HCV infection related B-NHL subtypes include MZL and DLBCL lymphomas. HCV-positive NHL patients usually present with older age at diagnosis, higher LDH, and more extranodal disease. The standard chemo-immunotherapy tolerance is generally good. Antiviral treatment achieves virological and hematological remission in HCV associated indolent lymphoma. More aggressive lymphoma requires combination of antiviral treatment and chemotherapy.

    pdf7p kequaidan1 16-11-2019 8 0   Download

  • All-oral combination of direct-acting antivirals could lead to higher sustained virologic response (SVR) in hepatitis C virus (HCV)-infected patients. In the present study, we examined the efficacy and safety of the dual oral treatment with HCV nonstructural protein (NS) 5A inhibitor daclatasvir (DCV) plus HCV NS3/4A inhibitor asunaprevir (ASV) for 24 weeks in real-world HCV genotype 1-infected Japanese individuals.

    pdf6p viwashington2711 04-12-2019 4 0   Download

  • Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients...

    pdf5p thulanh17 27-10-2011 43 3   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohor

    pdf13p panasonic02 15-12-2011 50 2   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands

    pdf7p panasonic04 19-12-2011 30 2   Download



p_strKeyword=Hepatitis c treatment

nocache searchPhinxDoc


Đồng bộ tài khoản